Skip to main content
. 2009 Apr 8;5:213–224. doi: 10.2147/vhrm.s3302

Figure 1.

Figure 1

Probability of achieving a SBP <140 mmHg at Weeks 7/8 across a range of baseline SBP following treatment with irbesartan/hydrochlorothiazide (HCTZ), irbesartan, and HCTZ. Results from the RAPiHD study. Reproduced with permission from Franklin S, Lapuerta P, Cox D, Donovan M. Initial combination therapy with irbesartan/hydrochlorothiazide for hypertension: an analysis of the relationship between baseline blood pressure and the need for combination therapy. J Clin Hypertens (Greenwich). 2007; 9(12 Suppl):15–22.59 Copyright © 2007 John Wiley and Sons, Inc.